LG Chem acquires Aveo Pharmaceuticals for $566 million
naver.com
news
2022-10-18 18:51:00

LG Chem CEO Shin Hak-cheol [LG CHEM] LG Chem acquired Nasdaq-listed Aveo Pharmaceuticals for $566 million, the Korean chemical company said Tuesday. The purchase will be handled by LG Chem Life Science Innovation Center, LG Chem's wholly-owned U.S. subsidiary. The deal will take some three to six months to be completely closed. Established in 2002 in Boston, Aveo is a pharmaceutical company specializing in cancer treatments. It developed Fotivda, a treatment for kidney cancer, and acquired use approval from the U.
